BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Increased Market Demand for Ulthera's Ultrasound Platform Technology Fuels Installation of 1,000th System Worldwide


7/25/2012 9:04:25 AM

MESA, AZ--(Marketwire - July 25, 2012) -

Ulthera, Inc. -- a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology -- today announced that more than 1,000 Ulthera Systems have been sold globally while treatments performed using the System have surpassed 100,000.

In the first half of 2012, expansion into Latin America as well as further penetration of markets in Europe, Asia and North America continued to accelerate quarterly sales growth. According to Matthew Likens, president and CEO of Ulthera, "There has been a significant increase in the number of Ultherapy procedures performed this year, making it apparent that the word is out; both physicians and consumers have discovered that Ultherapy is the most consistently efficacious non-surgical procedure to lift and tighten skin."

Likens added, "Our goal as an organization is to reward those customers who have invested in our technology by bringing them more value during each year of ownership. This value will be realized through expanded clinical indications, elevated marketing programs, and ongoing product enhancements."

The Ulthera System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication, and its signature procedure, Ultherapy, is a non-invasive treatment of the face to achieve a brow lift. The Ulthera System -- which combines time-honored ultrasound imaging with focused ultrasound therapy -- has been available internationally since 2008 and in the US since September 2009.

About Ulthera
Ulthera®, Inc. is a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® -- the procedure enabled by the System -- is a non-invasive treatment of the face to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.


Media Contact:
Lindsey Karberg
Ulthera, Inc.
480.336.1744
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

Ulthera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->